phone icon  Int'l : +1-503-894-6022
Allied Market Research
0
Shopping Cart is Empty..
$ 0

In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020.

Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market. Widespread knowledge of healthcare & its benefits, and cost effectiveness are some top impacting factors of the global IVD market. The stringent regulatory policies and reimbursement issues are limiting the growth of the market. Furthermore, the rising demand for technologically advanced diagnosis devices and increased spending capabilities of consumers on health care provides huge potential for IVD in Asia Pacific market. 

IVD Techniques Market Analysis

Global IVD techniques market is been segmented based on immunoassays, clinical chemistry, point of care, molecular diagnostics, hematology, coagulation, microbiology and other clinical techniques. Point of care is the highest revenue-generating segment in the overall IVD techniques market. Molecular diagnostics is the fastest growing technique in the in the overall IVD techniques market due to its ability to detect the primary cause of the disease accurately

IVD Product Type Market Analysis

The product type segment is been segmented based on instruments, reagents, data management systems and services. Instruments hold the highest market share in the global IVD market followed by reagents. Reagents market is also growing at a faster pace. As it is mostly used in various equipment and play a key role in the overall diagnosis process. Rise in the usage of diagnostic devices in which reagents are required for performing diagnosis tests, is the major factor that drives the product type market. 

IVD Usability Market Analysis

Usability segment is classified as disposable and reusable IVD devices. Doctors and clinicians currently prefer disposable devices, to avoid infections. Still, reusable IVD device holds the largest revenue share in the global IVD usability market. Cost effectiveness as a benefit of reusable devices is driving the growth of usability market.

IVD Applications Market Analysis

The application area is segmented based on infectious diseases, diabetes, cancer/oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectious diseases generated the highest revenue for current and forecast period mainly due to rise in the incidences of infectious diseases. HIV/AIDS application market is the second largest revenue generating applications segment and would remain the second largest through 2020.

IVD End User Market Analysis

Hospitals, laboratories, academics, point of care testing and others are the end users of global IVD market. Academic institutions provide trainings of IVD to the students. Laboratories generate the highest revenue followed by point of care for global end user market. Rise in the number of laboratories in Asia Pacific regions and increased awareness about health care and its benefits are contributing towards the growth of laboratories market, which in turn drives the global IVD end users market.

IVD Geography Market Analysis

The detailed analysis of the global IVD market is done in various regions such as North America, Europe, Asia Pacific and Rest of World. North America is the largest revenue generating region in all segments of global IVD market, whereas Asia Pacific region is fastest growing region amongst the regions studied.

IVD Competitive Analysis

The study of top ten players in the global market reveals strategies adopted to maintain their position in the competitive market. Strategic analysis of the top players reveals that market players are adopting product launch as their key developmental strategy in the market, as the market players are innovating novel products to expand their product line. Acquisitions and approvals are some additional strategies adopted by the companies in the market to enhance their services and expand their reach across the globe.

IVD High Level Analysis

The market exploration provides a clear view of global IVD market. Porter’s five-force model helps in analyzing market players, new entrants in the market and the novel strategies adopted by them. In the current business scenario, IVD market has moderate bargaining power of supplier due to existence of brand loyalty. Varying product differentiation would lead to moderate buyers’ bargaining. High entry barriers lead to lower threat of new entrants. Intersegment substitution leads to lower threat of Substitute. The value chain analysis reveals the key intermediaries involved in the supply chain. Raw material suppliers, medical device manufacturers, distributors, service providers and end users are the various stakeholders involved in the supply chain of IVD market.

Reason For Study

IVD is the oldest technique for diagnosis of the disease. With increase in incidences of chronic and infectious diseases and rise in healthcare awareness amongst patients, the market is opportunistic in different geographies. As there is a shift from traditional diagnostic devices to advanced diagnostic devices, IVD would prove to be a lucrative market in future.

IVD

KEY BENEFITS

  • Assessments are made according to the current business scenario and the future market trends are forecast for the period 2013-2020, with the base figures of the year 2013
  • The analysis gives a wider view of the global market including its market trends, market structure, limiting factors and opportunities for the market
  • Porter’s five force’s model helps in analyzing the potential of buyers & suppliers, and the competitive sketch of the market, which would guide the market players to develop strategies accordingly
  • The value chain analysis provides a systematic study on the key intermediaries involved, which would in turn help the stakeholders in the market to make appropriate strategies
  • The advantages of the market are analyzed to help the stakeholders identify the opportunistic areas in a comprehensive manner

KEY MARKET SEGMENTS

MARKET BY TECHNIQUES

  • Immunoassays
  • Clinical Chemistry
  • Point Of Care
  • Molecular Diagnostics
  • Hematology
  • Coagulation
  • Microbiology
  • Other clinical techniques

MARKET BY PRODUCT TYPE 

  • Instruments
  • Reagents
  • Data management systems
  • Services

MARKET BY USABILITY

  • Disposable
  • Reusable 

MARKET BY APPLICATIONS

  • Infectious Diseases
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing
  • HIV/AIDS
  • Others

MARKET BY END USER

  • Hospitals
  • Laboratories
  • Academics
  • Point of Care Testing
  • Others

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • Rest of World
* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Title/ Chapter Name

Chapter: 1. INTRODUCTION

1.1 Report description
1.2 Key market segments
1.3 Research methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

Chapter: 2. EXECUTIVE SUMMARY

Chapter: 3. MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors for the in vitro diagnostic market

3.2.2 Top investment pockets
3.2.3 Top winning strategies

3.3 Porter five forces model

3.3.1 Brand loyalty leads to moderate bargaining power of supplier
3.3.2 Varying product differentiation would lead to moderate bargaining power of buyers
3.3.3 Low threat from new entrants due to high entry barriers
3.3.4 Less intersegment substitution leads to lower threat Of substitute
3.3.5 Moderate competitive rivalry

3.4 Government regulations
3.5 Value chain analysis
3.6 Case studies

3.6.1 Case Study 1: Positioning of new IVD Platform by Life Science
3.6.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system

3.7 Key technology trends

3.7.1 Medical automation technologies
3.7.2 Emerging markets in digital pathology
3.7.3 Omics and IVD
3.7.4 Genetics tests and IVD
3.7.5 Point of care testing:
3.7.6 Personalized medicine propelling growth:
3.7.7 Emerging diagnostic technologies and impact on IVD

3.8 Market dynamics

3.8.1 Drivers

3.8.1.1 Increasing incidences of chronic and infectious diseases
3.8.1.2 Technological advancements in IVD
3.8.1.3 Emergence of minimal invasive technologies
3.8.1.4 Increasing government expenditures on healthcare
3.8.1.5 Increase in popularity personalized medicine approach

3.8.2 Restraints

3.8.2.1 Unclear reimbursement policies
3.8.2.2 Stringent Regulatory policies

3.8.3 Opportunities

3.8.3.1 Potential Opportunities for outsourcing
3.8.3.2 Convergence of new Technologies.

Chapter: 4. GLOBAL IVD MARKET BY TECHNIQUES

4.1 Immunoassay/Immunochemistry
4.2 Hematology

4.2.1 High throughput analyzer
4.2.2 Medium throughput analyzer
4.2.3 Low throughput analyzer

4.3 Clinical chemistry

4.3.1 Urine chemistry analyzers
4.3.2 Blood gas electrolyte analyzers
4.3.3 Others

4.4 Coagulation
4.5 Microbiology

4.5.1 Blood culture
4.5.2 Pathological culture
4.5.3 Identification & antibiotic susceptibility testing
4.5.4 Others

4.6 Molecular diagnostics

4.6.1 Infectious diseases
4.6.2 Oncology
4.6.3 Genetic diseases
4.6.4 Blood screening
4.6.5 Others

4.7 Point of care
4.8 Other clinical techniques

4.8.1 Clinical centrifuges
4.8.2 Tissue diagnosis
4.8.3 Sample processors
4.8.4 Flow cytometry
4.8.5 Cytology

Chapter: 5. GLOBAL IVD MARKET BY PRODUCT TYPE

5.1 Instruments
5.2 Reagents
5.3 Data management system hardware/software
5.4 Services

Chapter: 6. GLOBAL IVD MARKET BY USABILITY

6.1 Disposable IVD devices
6.2 Re-Usable IVD devices

Chapter: 7. GLOBAL IVD MARKET BY APPLICATION

7.1 Infectious diseases
7.2 Diabetes
7.3 Cancer/Oncology
7.4 Cardiology
7.5 Autoimmune diseases
7.6 Nephrology
7.7 Drug testing
7.8 HIV/AIDS
7.9 Others

Chapter: 8. GLOBAL IVD MARKET BY END USERS

8.1 Hospitals
8.2 Laboratory
8.3 Academics
8.4 Point-of-Care Testing
8.5 Others

Chapter: 9. GLOBAL IVD MARKET BY GEOGRAPHY

9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 RoW

Chapter: 10. COMPANY PROFILES

10.1 Alere Inc

10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Business performance
10.1.4 Key Strategies and developments
10.1.5 SWOT analysis of Alere

10.2 Biomerieux

10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Business performance
10.2.4 Key Strategies and developments

10.2.4.1 Primary STRATEGIES: APPROVAL
10.2.4.2 Secondary strategies: Acquisition

10.2.5 SWOT analysis of BioMerieux

10.3 Danaher Corporation.

10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Business performance
10.3.4 Key Strategies and development

10.3.5 SWOT analysis of Danaher

10.4 Roche Diagnostics.

10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Business performance
10.4.4 Key Strategies and developments
10.4.5 SWOT analysis of Roche

10.5 Becton Dickinson And Company

10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Business performance
10.5.4 Key Strategies and development

10.5.4.1 Primary strategies: product launch
10.5.4.2 Secondary strategies: Acquisition and Approval

10.5.5 SWOT analysis of Becton Dickinson and Company

10.6 Bio-Rad Laboratories

10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Business performance
10.6.4 Key Strategies and developments
10.6.5 SWOT analysis of Bio-Rad Laboratories

10.7 Abbott Laboratories

10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Business Performance
10.7.4 Key Strategies and developments
10.7.5 SWOT analysis of Abbott Laboratories

10.8 Bayer AG.

10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Business Performance
10.8.4 Key Strategies and Development
10.8.5 SWOT analysis of Bayer AG

10.9 Arkray Inc.

10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Key Strategies and development

10.9.3.1 Primary strategies
10.9.3.2 Secondary strategies

10.9.4 SWOT analysis of Arkray

10.10 Sysmex

10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Business performance
10.10.4 Key strategies and developments

10.10.4.1 Primary strategies: partnership
10.10.4.2 Secondary strategies: approval

10.10.5 SWOT analysis of Sysmex

10.11 Johnson & Johnson

10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Business Performance
10.11.4 Key Strategies and  Development

10.11.4.1 Primary strategies: partnership
10.11.4.2 Secondary strategies

10.11.5 SWOT analysis of Johnson & Johnson

10.12 Siemens

10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Business performance
10.12.4 Key Strategies and development
10.12.5 SWOT analysis of Siemens

 

LIST OF TABLES

TABLE 1   IVD MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 2   PORTERS FIVE FORCES MODEL
TABLE 3   GLOBAL INCIDENCES OF DISEASES
TABLE 4   GLOBAL IVD MARKET BY TECHNIQUE, 2013-2020 ($BILLION)
TABLE 5   GLOBAL IMMUNOASSAY TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 6   GLOBAL HEMATOLOGY TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 7   GLOBAL CLINICAL CHEMISTRY TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 8   GLOBAL COAGULATION TECHNIQUE MARKET BY GEOGRAPHY,  2013-2020 ($BILLION)
TABLE 9   GLOBAL MICROBIOLOGY TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 10  GLOBAL MOLECULAR DIAGNOSTICS TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 11  POINT OF CARE TECHNIQUE MARKET,2013-2020,($BILLION)
TABLE 12  GLOBAL OTHER TECHNIQUES MARKET BY GEOGRAPHY,  2013.-.2020, -.($BILLION)
TABLE 13  GLOBAL IVD BY PRODUCT TYPE MARKET, 2013-2020 ($BILLION)
TABLE 14  GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 15  GLOBAL REAGENTS MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 16  GLOBAL DATA MANAGEMENT SOFTWARE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 17  GLOBAL SERVICES MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 18  GLOBAL IVD USABILITY MARKET, 2013-2020 ($BILLION)
TABLE 19  GLOBAL IVD DISPOSABLE DEVICES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 20  GLOBAL IVD REUSABLE DEVICES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 21  LIST OF MANUFACTURERS WITH RE-USABLE IVD DEVICES
TABLE 22  GLOBAL IVD APPLICATIONS MARKET, 2013-2020 ($BILLION)
TABLE 23  GLOBAL IVD INFECTIOUS DISEASES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 24  GLOBAL IVD DIABETES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 25  GLOBAL IVD CANCER/ONCOLOGY MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 26  GLOBAL IVD CARDIOLOGY MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 27  GLOBAL IVD AUTOIMMUNE DISEASES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 28  GLOBAL IVD NEPHROLOGY MARKET BY GEOGRAPHY, 2013-2020,- ($BILLIONS)
TABLE 29  GLOBAL IVD DRUG TESTING MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 30  GLOBAL IVD HIV/AIDS MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 31  GLOBAL IVD OTHER DISEASES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 32  GLOBAL IVD MARKET BY END USER ,2013-2020,($BILLION)
TABLE 33  GLOBAL IVD HOSPITALS MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 34  GLOBAL IVD LABORATORY MARKET BY GEOGRAPHY,2013-2020,($BILLIONS)
TABLE 35  GLOBAL IVD ACADEMICS MARKET BY GEOGRAPHY, 2013- 2020 ($BILLIONS)
TABLE 36  GLOBAL IVD POINT OF CARE TESTING MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 37  GLOBAL IVD OTHER MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 38  GLOBAL IVD MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 39  GLOBAL IVD NORTH AMERICA MARKET, 2013-2020 ($BILLION)
TABLE 40  GLOBAL IVD EUROPE MARKET, 2013-2020 ($BILLION)
TABLE 41  GLOBAL IVD ASIA PACIFIC MARKET, 2013-2020 ($BILLION)
TABLE 42  GLOBAL IVD REST OF THE WORLD MARKET, 2013-2020 ($BILLION)
TABLE 43  ALERE COMPANY SNAPSHOT
TABLE 44  BIOMERIEUX COMPANY SNAPSHOT
TABLE 45  DANAHER COMPANY SNAPSHOT
TABLE 46  ROCHE COMPANY SNAPSHOT
TABLE 47  BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 48  BIO-RAD LABORATORIES SNAPSHOT
TABLE 49  ABBOTT LABORATORIES SNAPSHOT
TABLE 50  BAYER AG COMPANY SNAPSHOT
TABLE 51  ARKRAY COMPANY SNAPSHOT
TABLE 52  SYSMEX COMPANY SNAPSHOT
TABLE 53  JOHNSON & JOHNSON COMPANY SNAPSHOT
TABLE 54  SIEMENS COMPANY SNAPSHOT

 

LIST OF FIGURES

FIG. 1   TOP IMPACTING FACTORS
FIG. 2   TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2013-2020.
FIG. 3   TOP WINNING STRATEGIES
FIG. 4   TOP WINNING STRATEGIES
FIG. 5   VALUE CHAIN ANALYSIS FOR IVD MARKET
FIG. 6   KEY FINANCIALS OF ALERE BY SALES 2013
FIG. 7   KEY FINANCIALS OF NET REVENUE BY GEOGRAPHY 2013
FIG. 8   SWOT ANALYSIS OF ALERE
FIG. 9   KEY FINANCIALS OF BREAKDOWN OF SALES BY TECHNOLOGY
FIG. 10  KEY FINANCIALS OF BREAKDOWN OF SALES BY GEOGRAPHY
FIG. 11  SWOT ANALYSIS OF BIOMERIEUX
FIG. 12  KEY FINANCIALS OF DANAHER SALES BY SEGMENT 2013
FIG. 13  KEY FINANCIALS OF DANAHER SALES BY GEOGRAPHY 2013
FIG. 14  SWOT ANALYSIS OF DANAHER
FIG. 15  KEY FINANCIALS OF ROCHE REVENUES BY SEGMENT 2012
FIG. 16  KEY FINANCIALS OF ROCHE SALES BY GEOGRAPHY 2013
FIG. 17  SWOT ANALYSIS OF ROCHE
FIG. 18  KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2013
FIG. 19  KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2013
FIG. 20  SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 21  KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUES BY SEGMENT 2013
FIG. 22  KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUES BY GEOGRAPHY 2013
FIG. 23  SWOT ANALYSIS OF BIO-RAD LABORATORIES
FIG. 24  KEY FINANCIALS OF ABBOTT LABORATORIES REVENUES BY SEGMENT 2013
FIG. 25  KEY FINANCIALS OF ABBOTT LABORATORIES REVENUES BY GEOGRAPHY 2013
FIG. 26  SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 27  KEY FINANCIALS OF BAYER AG COMPANY REVENUES BY SEGMENT 2013
FIG. 28  SWOT ANALYSIS OF BAYER AG
FIG. 29  SWOT ANALYSIS OF ARKRAY
FIG. 30  KEY FINANCIALS OF SYSMEX COMPANY REVENUES BY SEGMENT 2013
FIG. 31  KEY FINANCIALS OF SYSMEX COMPANY REVENUES BY GEOGRAPHY 2013
FIG. 32  SWOT ANALYSIS OF SYSMEX
FIG. 33  KEY FINANCIALS OF JOHNSON & JOHNSON COMPANY REVENUES BY SEGMENT 2013
FIG. 34  KEY FINANCIALS OF JOHNSON & JOHNSON COMPANY REVENUES BY GEOGRAPHY 2013
FIG. 35  SWOT ANALYSIS OF JOHNSON & JOHNSON
FIG. 36  KEY FINANCIALS OF SIEMENS COMPANY REVENUES BY SEGMENT 2013
FIG. 37  KEY FINANCIALS OF SIEMENS COMPANY REVENUES BY GEOGRAPHY 2013
FIG. 38  SWOT ANALYSIS OF SIEMENS

In vitro diagnostics field has evolved with technological advancements in the diagnostic techniques and awareness about the healthcare in emerging market. One key feature that makes this market attractive is its diagnostic solutions in diagnosis of variety of diseases and its widespread applications area. In vitro diagnostics is used in wide range of applications such as diagnosis of infectious diseases, diabetes, oncology/cancer, cardiology diseases, autoimmune diseases, nephrology, drug testing, HIV/AIDS, etc. Increasing awareness amongst public about healthcare, cost effective diagnostic solutions, accurate and faster test results are some of the factors enhancing the growth of in vitro diagnostics market world over, especially in regions such as India, China, Japan and so on. Increasing incidences of chronic and infectious diseases, use of automated instruments, point of care diagnostic solutions, and increased government expenditure on healthcare in all the regions (North America, Europe, Asia Pacific, and Rest-of-World) are the driving factors for the growing in vitro diagnostics market. Stringent regulations, policies and unclear reimbursement rules are some restraining factors for this industry

This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.

SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$4515
$5325
$7350
$10680
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Limited to 5 authorized users

Up to 25 users


unlimited within company / enterprise
Copy/Paste
Allowed up to 20% of the content
Allowed up to 25% of the content
Allowed up to 50% of the content
allowed 100%

Printing
One print only

Five Prints

Unlimited for internal use
Unlimited for internal use
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User
$4515
Group User
$5325
Site User
$7350
Global User
$10680
buy now

Discount will be applied in cart.
First time buyer ?
Check offers and discount
on this report
GET DISCOUNT
Need More Information
phone_n +1-503-894-6022

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They also enhance the overall safety or functionality of the product during storage or use. The world pharmaceutical excipients market size is evaluated to reach 728.4 kilo tons in volume by 2020, accounting for a revenue of $6.4 billion. Besides this, world pharmaceuticals excipients market would reach $6.4 billion by 2020 at a CAGR of 7.6% during 2015 and 2020
    Feb 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    In-vitro fertilization is an assisted reproductive technology, which involves a series of procedures for treating infertility problems. It involves the fertilization of the ovum in-vitro, followed by implantation of the embryo into a women’s uterus.
    Jan 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    The mHealth market is in its infancy and is expected to yield significant revenues with increasing awareness level and favorable regulatory impositions specific to the quality and feasibility of mobile-based medical devices. Penetration of mobile phones in healthcare has created a long lasting impact on the overall health industry.
    Nov 2013 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues and other body fluids, which are derived from the human body to detect diseases, conditions and infections. The tests can be performed in stand-alone laboratory, hospital based laboratory and point of care. Some of the significant technologies incorporated in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation.
    Feb 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. It causes skeletal muscle cells and fat tissues to absorb glucose from the blood. The global human insulin market is expected to grow at healthy CAGR during the forecast period due to high prevalence of diabetes, worldwide. In-depth analysis of the global human insulin market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities.
    Aug 2016 | View Details >>
  • ...
    Empty capsules enable users to fill bulking agents, fillers, colorants on their own in a capsule. It provides users scope to blend various ingredients and decide specifications of capsules. It is cheaper, safer, and organic solution compared to readymade capsules. Capsules filled with vegetables, herbs, and spices is an alternative for healthy food for children. Empty capsules eliminate the need to go to pharmacy to find tablets with necessary supplements.
    Aug 2016 | View Details >>
  • ...
    Cryosurgery or Cryotherapy is a minimally invasive treatment that subjects the use of extremely cold temperatures to freeze and destroy diseased tissues, largely used in the treatment of cancer. To freeze the diseased cells, (inside or outside the body) liquid nitrogen, argon gas, carbon dioxide gas & dimethyl ether- propane are applied. Some image guiding techniques such as ultrasound, computed tomography (CT) or magnetic resonance (MR) are also used in the practice of cryotherapy.
    Aug 2016 | View Details >>